Barnes Group (B)
(Delayed Data from NYSE)
$36.26 USD
0.00 (0.00%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $36.24 -0.02 (-0.06%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
B 36.26 0.00(0.00%)
Will B be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for B based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for B
Analysts Estimate Barnes Group (B) to Report a Decline in Earnings: What to Look Out for
Reasons Why You Should Avoid Betting on Barnes (B) Stock Now
B: What are Zacks experts saying now?
Zacks Private Portfolio Services
Barnes (B) Expands East Granby MRO Facility for Engine Projects
Barnes (B) Divests Spring & Hanggi Units to One Equity Partners
Barnes Group (B) Q4 Earnings Top Estimates, Revenues Miss
Other News for B
Genomma Lab Internacional Announces Results for the First Quarter 2024
Leqembi® revenue totaled JPY 2.83 billion in the first quarter 2024
Hexagon partners with Microsoft to redefine manufacturing with cloud technology
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
BioArctic and Eisai sign research evaluation agreement regarding BAN2802